Pharsight

1. Baxdela patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9539250	MELINTA	Salt and crystalline forms thereof of a drug	Oct, 2025 (2 years from now)
US8273892	MELINTA	Salt and crystalline forms thereof of a drug	Aug, 2026 (2 years from now)
US8871938	MELINTA	Process for making quinolone compounds	Sep, 2029 (5 years from now)
USRE46617	MELINTA	Process for making quinolone compounds	Dec, 2029 (6 years from now)
US7728143	MELINTA	Salt and crystalline forms thereof of a drug	Jun, 2031 (7 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8969569	MELINTA	Salt and crystalline forms thereof of a drug	Oct, 2025 (2 years from now)
US8648093	MELINTA	Salt and crystalline forms thereof of a drug	Oct, 2025 (2 years from now)
US8252813	MELINTA	Salt and crystalline forms thereof of a drug	Oct, 2026 (3 years from now)
US7635773	MELINTA	Sulfoalkyl ether cyclodextrin compositions	Mar, 2029 (5 years from now)
US9200088	MELINTA	Sulfoalkyl ether cyclodextrin compositions	Mar, 2029 (5 years from now)
US8410077	MELINTA	Sulfoalkyl ether cyclodextrin compositions	Mar, 2029 (5 years from now)
US9750822	MELINTA	Sulfoalkyl ether cyclodextrin compositions	Mar, 2029 (5 years from now)
US9493582	MELINTA	Alkylated cyclodextrin compositions and processes for preparing and using the same	Feb, 2033 (9 years from now)